GLMD
NASDAQ
IL
Galmed Pharmaceuticals Ltd. - Ordinary Shares
$0.54
▲ +$0.01
(+1.89%)
Vol 15K
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$4.1M
ROE
-47.8%
Margin
-424.2%
D/E
0.00
Beta
0.31
52W
$1–$4
Wall Street Consensus
6 analysts · Apr 20260
Strong Buy
0
Buy
3
Hold
1
Sell
2
Strong Sell
0.0%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 60.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.52 | $-0.80 | $-0.28 |
| Sep 2025 | $-0.55 | $-0.33 | +$0.22 |
| Jun 2025 | $-0.85 | $-0.63 | +$0.22 |
| Mar 2025 | $-0.91 | $-0.62 | +$0.29 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -$1.9M | -$3.2M | -$1.1M | -$2.5M | -$1.9M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -48.4% | -46.2% | -48.4% | -48.4% | -48.4% | -47.8% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -424.2% | -424.2% | -424.2% | -424.2% | -424.2% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 8.71 | 9.02 | 8.71 | 8.71 | 8.71 | 7.98 |
Key Ratios
ROA (TTM)
-42.6%
P/S (TTM)
1.78
P/B
0.3
EPS (TTM)
$-3.60
CF/Share
$-6.77
52W High
$3.61
52W Low
$0.74
$0.74
52-Week Range
$3.61
Financial Health
Free Cash Flow
-$1.9M
Cash
$3.3M
As of Sep 30, 2025
How does GLMD compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
GLMD valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
1.8
▼
86%
below
peers
(12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
0.3
▼
88%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
GLMD profitability vs Biotechnology peers
ROE
-47.8%
▲
29%
above
peers
(-67.3%)
vs Peers
vs Industry
Below avg
Net margin
-424.2%
▼
48%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-42.6%
▲
9%
above
peers
(-46.7%)
vs Peers
vs Industry
In line
GLMD financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
8.0
▲
80%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
0.3
▼
68%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
GLMD fundamentals radar
GLMD
Peer median
Industry
GLMD profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
GLMD vs peers: key metrics
Top Holders
Top 5: 3.15%Two Sigma Investments, LP
1.70%
$54K
Citadel Advisors Llc
0.58%
$18K
Two Sigma Advisers, LP
0.48%
$15K
Two Sigma Securities, LLC
0.21%
$7K
Jane Street Group, LLC
0.18%
$6K
As of Dec 31, 2025
Latest News
No related news yet